Diagnoses of ADHD continue to rise among U.S. youth, affecting one in every nine U.S. kids. Approximately 11.4% of U.S. children (7.1 million) have received an ADHD diagnosis at some point, and 10.5% ...
An ongoing shortage of medication for attention deficit hyperactivity disorder is affecting millions—and with no end in sight. The Food and Drug Administration first announced a shortage of Adderall, ...
The Drug Enforcement Administration has increased the production limit for Takeda Pharmaceutical’s ADHD drug Vyvanse and its generic versions by about 24% to address the medicine’s ongoing shortage in ...
Ashley Hanson, Ph.D., assistant professor in the University of Alabama at Birmingham’s Department of Psychiatry and Behavioral Neurobiology, shares insights about how ADHD can impact work life and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback